Characterization of Leukocyte- and Platelet-Rich Plasma Derived from Female Collage Athletes: A Cross-Sectional Cohort Study Focusing on Growth Factor, Inflammatory Cytokines, and Anti-Inflammatory Cytokine Levels.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
02 Sep 2023
Historique:
received: 07 08 2023
revised: 31 08 2023
accepted: 01 09 2023
medline: 11 9 2023
pubmed: 9 9 2023
entrez: 9 9 2023
Statut: epublish

Résumé

Platelet-rich plasma (PRP) has been increasingly used in sports medicine owing to its various advantages. The purpose of our project was to standardize the parameters before performing large-scale clinical trials in the near future to precisely evaluate individual PRP quality. To examine the effects of regular exercise on PRP quality, this study focused on young female athletes, who have been relatively less studied. Blood samples were obtained from female college athletes (n = 35) and ordinary healthy adults (n = 30), which were considered as controls, and leukocyte-rich PRP (L-PRP) was prepared manually. Body composition indices were determined using a bathroom weight scale equipped with an impedance meter. Growth factors and cytokines were quantified using ELISA kits. Platelet-derived growth factor-BB (PDGF-BB) and Transforming-growth factors β1 (TGFβ1) levels (per platelet) in L-PRP were significantly lower in female athletes than in controls. In contrast, Interleukin-1β and Interleukin 1 receptor antagonist (IL-1RA) levels (per platelet and L-PRP) in L-PRP were significantly higher in athletes, and this difference was more prominent in IL-1RA. These findings suggest that L-PRP from athletes may facilitate the inflammatory phase of the healing process by regulating the pro-inflammatory and anti-inflammatory balance. These chemical compositions can be adopted as "must-check" parameters to characterize individual PRP preparations prior to clinical trials.

Identifiants

pubmed: 37686398
pii: ijms241713592
doi: 10.3390/ijms241713592
pmc: PMC10488049
pii:
doi:

Substances chimiques

Cytokines 0
Interleukin 1 Receptor Antagonist Protein 0
Intercellular Signaling Peptides and Proteins 0
Anti-Inflammatory Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 21K09932
Organisme : Japan Society for the Promotion of Science
ID : 22K11496
Organisme : Japan Society for the Promotion of Science
ID : 23K10583

Références

Ann Anat. 2022 Feb;240:151853
pubmed: 34767933
Arthritis Res Ther. 2012 Aug 08;14(4):219
pubmed: 22894643
Endocr Rev. 2018 Oct 1;39(5):803-829
pubmed: 30010735
Int J Mol Sci. 2022 Sep 25;23(19):
pubmed: 36232597
Clin J Sport Med. 2011 Jul;21(4):344-52
pubmed: 21562414
PM R. 2023 Mar 16;:
pubmed: 36929699
Int J Mol Sci. 2020 Oct 21;21(20):
pubmed: 33096812
Br J Sports Med. 2015 Sep;49(18):1206-12
pubmed: 25940636
Lancet Child Adolesc Health. 2018 Mar;2(3):223-228
pubmed: 30169257
Physiol Rep. 2022 Aug;10(15):e15409
pubmed: 35923128
Curr Opin Endocrinol Diabetes Obes. 2022 Feb 1;29(1):44-51
pubmed: 34812202
J Orthop Surg Res. 2022 Oct 27;17(1):465
pubmed: 36303196
J Gend Specif Med. 2001;4(4):25-34
pubmed: 11727468
Front Physiol. 2018 Dec 19;9:1835
pubmed: 30618840
Mil Med. 2014 Jul;179(7):799-805
pubmed: 25003868
Arthrosc Sports Med Rehabil. 2023 May 20;5(3):e853-e858
pubmed: 37388884
Physiology (Bethesda). 2015 Jan;30(1):30-9
pubmed: 25559153
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Jun;85(6):638-46
pubmed: 9638695
Orthop J Sports Med. 2022 Dec 9;10(12):23259671221140888
pubmed: 36532150
Int J Oral Maxillofac Implants. 2001 Sep-Oct;16(5):693-9
pubmed: 11669252
Bioengineering (Basel). 2020 Jul 30;7(3):
pubmed: 32751638
Transl Pediatr. 2017 Jul;6(3):144-149
pubmed: 28795004
J Sport Health Sci. 2022 Jan;11(1):104-114
pubmed: 34052518
PLoS One. 2014 Feb 28;9(2):e90538
pubmed: 24587389
Odontology. 2015 May;103(2):126-35
pubmed: 26040505
Bioengineering (Basel). 2023 Mar 25;10(4):
pubmed: 37106596
Stem Cell Res Ther. 2015 Sep 15;6:173
pubmed: 26373929
Mayo Clin Proc. 2013 Sep;88(9):996-1009
pubmed: 24001492
Br J Sports Med. 2015 Jul;49(14):943-50
pubmed: 26136179
Curr Rev Musculoskelet Med. 2013 Jun;6(2):173-81
pubmed: 23536179
PM R. 2011 Mar;3(3):226-50
pubmed: 21402369
Front Physiol. 2019 Jan 15;9:1834
pubmed: 30697162
J Exp Orthop. 2019 Feb 2;6(1):4
pubmed: 30712144
J Orthop. 2016 Mar 24;13(2):A1-4
pubmed: 27053841
Cell Tissue Res. 2019 May;376(2):143-152
pubmed: 30758709
Am J Sports Med. 2018 Feb;46(2):409-419
pubmed: 29211968
Sports Health. 2012 Jul;4(4):302-11
pubmed: 23016101
Biomed Res Int. 2018 May 21;2018:6389157
pubmed: 29951539
J Hum Kinet. 2011 Dec;30:85-97
pubmed: 23487362
EFORT Open Rev. 2021 Apr 1;6(4):225-235
pubmed: 34040800
Eur J Clin Nutr. 2012 Dec;66(12):1351-5
pubmed: 23093345

Auteurs

Tomoharu Mochizuki (T)

Department of Orthopaedic Surgery, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan.

Takashi Ushiki (T)

Division of Hematology and Oncology, Graduate School of Health Sciences, Niigata University, Niigata 951-9518, Japan.
Department of Transfusion Medicine, Cell Therapy and Regenerative Medicine, Niigata University Medical and Dental Hospital, Niigata 951-8520, Japan.
Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University, Niigata 951-8510, Japan.

Katsuya Suzuki (K)

Department of Transfusion Medicine, Cell Therapy and Regenerative Medicine, Niigata University Medical and Dental Hospital, Niigata 951-8520, Japan.

Misato Sato (M)

Department of Transfusion Medicine, Cell Therapy and Regenerative Medicine, Niigata University Medical and Dental Hospital, Niigata 951-8520, Japan.

Hajime Ishiguro (H)

Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University, Niigata 951-8510, Japan.

Tatsuya Suwabe (T)

Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University, Niigata 951-8510, Japan.

Mutsuaki Edama (M)

Department of Health and Sports, Faculty of Health Sciences, Niigata University of Health and Welfare, Niigata 950-3102, Japan.

Go Omori (G)

Department of Health and Sports, Faculty of Health Sciences, Niigata University of Health and Welfare, Niigata 950-3102, Japan.

Noriaki Yamamoto (N)

Department of Orthopaedic Surgery, Niigata Rehabilitation Hospital, Niigata 950-3304, Japan.

Tomoyuki Kawase (T)

Division of Oral Bioengineering, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH